HTWR News 84.98 Heartware International (HTWR)

New Post Public Reply Private Reply Replies (0) Message Board

Apr 18, 2014 at 3:30 AM

Heartware International (HTWR) 84.98 $HTWR

Upgrade Alert for HeartWare International (HTWR)
Comtex SmarTrend(R) - Tue Apr 15, 6:59AM CDT
HeartWare International (NASDAQ:HTWR) was upgraded from Perform to Outperform at Oppenheimer today. The stock closed yesterday at $86.57 on volume of 410,000 shares, above average daily volume of 215,000. HeartWare International has overhead space with shares priced $86.57, or 18.0% below the average consensus analyst price target of $105.64. The stock should find initial resistance at its 200-day moving average (MA) of $88.89 and further resistance at its 50-day MA of $94.10.

HeartWare International Rises 6.53% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Mon Apr 14, 5:52PM CDT
HeartWare International (NASDAQ:HTWR) traded in a range yesterday that spanned from a low of $81.38 to a high of $86.86. Yesterday, the shares gained 6.5%, which took the trading range above the 3-day high of $85.84 on volume of 410,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Improvement in Cardiac Function with Particulate ECM alone and adjunct to LVAD Demonstrated in Bovine Model
Business Wire - Mon Apr 14, 8:31AM CDT
New research presented Sunday at the 34th Annual meeting of the International Society for Heart and Lung Transplantation (ISHLT) demonstrated the CorMatrix particulate extracellular matrix (P-ECM) alone and as an adjunct to HeartWare International Inc.'s left ventricular assist device (LVAD) improved cardiac function in a bovine ischemic heart failure model, as compared to LVAD alone. Mark S. Slaughter, M.D., of the Department of Cardiovascular and Thoracic Surgery and his research team from the University of Louisville, Louisville, KY, presented data during the ISHLT Mechanical Circulatory Support: Bench to Bedside Session in his presentation entitled "Myocardial Regeneration and Recovery with Extracellular Matrix and LVAD Support" on Sunday Morning.

Downtrend Call Working As HeartWare International Stock Falls 12.7% (HTWR)
Comtex SmarTrend(R) - Fri Apr 11, 11:18AM CDT
SmarTrend identified a Downtrend for HeartWare International (NASDAQ:HTWR) on March 7th, 2014 at $92.57. In approximately 1 month, HeartWare International has returned 12.73% as of today's recent price of $80.79.

Heartware International Down to Sell - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 18, 2:20PM CDT
Heartware continues to make losses due to higher costs and expenses.

HeartWare Presentation At The 2014 Barclays Global Healthcare Conference To Be Webcast
PR Newswire - Fri Mar 07, 8:00AM CST
HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the 2014 Barclays Global Healthcare Conference at 10:15 a.m. EDT on Tuesday, March 11, 2014. The conference is being held March 11-13 at Loews Miami Hotel.

Thoratec Warns About HeartMate Controller - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 06, 2:00PM CST
Investors reacted negatively to the news, resulting in a 2.7% fall in THOR shares to $36.22 after the market closed yesterday

HeartWare Sees Narrower Loss but Misses Ests - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 03, 8:55AM CST
For full year 2013, HeartWare's loss was also narrower at $52.0 million or $3.24 per share compared with $86.6 million or $6.07 per share in 2012.

HeartWare International Reports Fourth Quarter 2013 Results
PR Newswire - Thu Feb 27, 6:00AM CST
HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced revenue of $53.1 million for the fourth quarter ended December 31, 2013, a 62% increase compared to $32.7 million in revenue for the same period of 2012. For the fiscal year 2013, the company generated revenue of $207.9 million, an 87% increase compared to revenue of $110.9 million in fiscal year 2012.

HeartWare Presentation At The Raymond James 35th Annual Institutional Investors Conference To Be Webcast
PR Newswire - Wed Feb 26, 3:00PM CST
HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the Raymond James 35th Annual Institutional Investors Conference at 4:35 p.m. EST on Tuesday, March 4, 2014. The conference is being held March 2-5 at JW Marriott Grande Lakes, Orlando, Florida.

Insider Trading Alert - HTWR, IDTI And RFMD Traded By Insiders
at The Street - Tue Feb 18, 9:30AM CST
Stocks with insider trader activity include HTWR, IDTI and RFMD

HeartWare Schedules Fourth Quarter Conference Call And Webcast
PR Newswire - Tue Feb 04, 4:21PM CST
HeartWare International, Inc. (NASDAQ:HTWR) has scheduled a conference call to discuss its financial results for the three months ended December 31, 2013, at 8:00 a.m. U.S. Eastern Standard Time on Thursday, February 27, 2014. The Company plans to release the financial results prior to the conference call.

HeartWare Presentation At The 2014 Leerink Global Healthcare Conference To Be Webcast
PR Newswire - Tue Feb 04, 2:00PM CST
HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the 2014 Leerink Global Healthcare Conference at 8:55 a.m. EST on Thursday, February 13, 2014. The conference is being held February 12-13 at the Waldorf Astoria in New York City.

29.9% Return Seen to Date on SmarTrend HeartWare International Call (HTWR)
Comtex SmarTrend(R) - Wed Jan 29, 9:48AM CST
SmarTrend identified an Uptrend for HeartWare International (NASDAQ:HTWR) on October 24th, 2013 at $76.93. In approximately 3 months, HeartWare International has returned 29.87% as of today's recent price of $99.90.

Uptrend Call Working As HeartWare International Stock Rises 34.9% (HTWR)
Comtex SmarTrend(R) - Wed Jan 22, 9:20AM CST
SmarTrend identified an Uptrend for HeartWare International (NASDAQ:HTWR) on October 24th, 2013 at $76.93. In approximately 3 months, HeartWare International has returned 34.86% as of today's recent price of $103.74.

HEARTWARE
at Investor's Business Daily - Tue Jan 14, 5:46PM CST
HEARTWARE (HTWR), an implantable heart-pump maker, said preliminary Q4 sales were $53 mil, up 62%, but below views for $58.4 mil. Shares dropped 9.9% to 93.

HeartWare gives weak revenue guidance
AP - Tue Jan 14, 5:07PM CST
FRAMINGHAM, Mass. (AP) — HeartWare International Inc. shares sank in after-hours trading Tuesday after the medical device company said that its revenue may fall short of market forecasts.

Shares of HTWR Up 34.2% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Jan 14, 5:01PM CST
SmarTrend identified an Uptrend for HeartWare International (NASDAQ:HTWR) on October 24th, 2013 at $76.93. In approximately 3 months, HeartWare International has returned 34.22% as of today's recent price of $103.25.

HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues
PR Newswire - Tue Jan 14, 3:45PM CST
HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that it expects revenues for the fourth quarter of 2013 will be approximately $53 million, bringing expected full-year 2013 revenues to approximately $208 million.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Qfin Holdings Faces Securities Fraud Class Action Challenges

Troubles Mount for Qfin Holdings Well, you don't need a crystal ball to see this storm brewing for Qfin Holdings, Inc. (NASDAQ:QFIN). On the heels of a nasty 18.91% nosedive in their stock price, a class action lawsuit is looming overhead like a mischievous cloud ready to rain on investors' parades. It's the kind of legal and financial brew that could leave shareholders...

Eastern Championship: Collegiate Cricket's U.S. Surge

Cricket's American Dream Marches On Out of the woodwork comes the Collegiate Cricket League's 2026 Eastern Championship set to unfold near Washington, D.C., from Nov. 6-8. Now, nobody's saying cricket is overtaking the popularity of football or basketball stateside, but this three-day slugfest at Hal & Berni Hanson Regional Park in Aldie, Virginia, isn't just for...

SAFE's New Website: Engineering Excellence and Faith

A Bold Digital Step for SAFE Structure Designs Now here's a move worth watching. SAFE Structure Designs, that U.S.-rooted defense contractor with its fingers in a multitude of engineering pies, just rolled out a fresh new face on the web. This isn't merely an online facelift; it's a declaration of ambition and capabilities. They're showcasing eight specialized divisions...

Lumentum Holders Question Marvell Deal Fairness: Legal Eyes

What's Brewing with Lumentum and Marvell? There's no denying the chatter on Wall Street when there's a potential shake-up, especially with a big merger at stake. We're staring down the barrel of an investigation concerning Lumentum Holdings Inc. (NASDAQ: LITE) and Marvell Technology, Inc.'s deal. The M&A Class Action Firm, helmed by Juan Monteverde, is the name leading...

Crude Insight: Refining Margins Expand, LNG Orders Rise

Refining Margins Stretch While LNG Orders Surge Well, folks, oil markets have sure been a rollercoaster lately. WTI futures danced all over the place, closing near $96 a barrel after brushing against both $93 and $99 earlier this week. Brent wasn't left out of the tango, setting at $103.60. Everyone's holding their breath each time these numbers come through. Energy...

Farmer Sentiment Rises, Hints of Cautious Optimism

Sifting Through October's Optimism: Farmers' Sentiments October saw a glimmer of hope in the agricultural sector as the Purdue University/CME Group Ag Economy Barometer inched upward from 123 to 126. Sure, it's not a fireworks display, but it's a far cry from doom and gloom. This slim gain in sentiment comes on the coattails of some government help through Agriculture...

BRIJ Medical Secures $5M: Paving Path for Product Launches

In a world where medical advancements keep shifting gears, BRIJ Medical just pulled a fast one by closing a $5 million financing round—outpacing their original $3 million target. What drove this sudden increase? Well, it's simple. Their existing investors spotted an opportunity too ripe to pass up, proving yet again, money talks when confidence backs it up. Expanding...

China's Health-Driven Poverty Approach Offers Global Lessons

China's Health Strategy in Poverty Reduction Here's a story that's got global implications tucked into its every corner: China, a country that's been trying to mesh healthcare with poverty reduction, has caught the eye of international observers. This insight was splashed across the latest Lancet Commission report, showcased at Tsinghua University on October 29. It seems...

ISU and Ares Forge Path in Solid-State Battery Tech

Solid-State Dreams Meet AI Magic Ah, the sweet sound of synergy. ISU Specialty Chemical and Ares Materials are brewing up something that could shake the battery world—solid-state cells juiced by AI-driven polymer magic. Now, the tech and finance geeks are likely on the edge of their seats. This isn't just another run-of-the-mill collab; it's a heavyweight match to speed...

Investors Slam Coastal Financial: Class Action Looms Large

The air's thick with tension as Coastal Financial Corporation (NASDAQ:CCB) finds itself embroiled in a securities class action lawsuit. Investors who grabbed shares between October 28, 2024, and July 29, 2026, are in the spotlight and urging those with losses to make a move by the December 1, 2026, lead plaintiff deadline. Sounds like a real mess, doesn't it? Well, it's a...